<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001874108</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001851194</issuerCik>
      <issuerName>Ventyx Biosciences, Inc.</issuerName>
      <secFileNumber>001-40928</secFileNumber>
      <issuerAddress>
        <com:street1>12790 EL CAMINO REAL, SUITE 200</com:street1>
        <com:city>SAN DIEGO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92130</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(858) 945-2393</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Nuss John</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>E-Trade Financial Corporation</name>
        <address>
          <com:street1>3 EDISON DRIVE</com:street1>
          <com:city>Alpharetta</com:city>
          <com:stateOrCountry>GA</com:stateOrCountry>
          <com:zipCode>30005</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>13161</noOfUnitsSold>
      <aggregateMarketValue>29682.07</aggregateMarketValue>
      <noOfUnitsOutstanding>70669131</noOfUnitsOutstanding>
      <approxSaleDate>12/19/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>12/17/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Units</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>34930</amountOfSecuritiesAcquired>
      <paymentDate>12/17/2024</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>SHARES TO BE SOLD TO COVER WITHHOLDING TAXES UPON VESTING OF RESTRICTED STOCK UNIT AWARDS</remarks>
    <noticeSignature>
      <noticeDate>12/19/2024</noticeDate>
      <signature>/s/ Austin Rutherford, as Attorney-in-Fact</signature>
    </noticeSignature>
  </formData>

</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2871}]
144
0001874108
XXXXXXXX
LIVE
0001851194
Ventyx Biosciences, Inc.
001-40928
12790 EL CAMINO REAL, SUITE 200
SAN DIEGO
CA
92130
(858) 945-2393
Nuss John
Officer
Common Stock
E-Trade Financial Corporation
3 EDISON DRIVE
Alpharetta
GA
30005
13161
29682.07
70669131
12/19/2024
NASDAQ
Common Stock
12/17/2024
Restricted Stock Units
Issuer
N
34930
12/17/2024
N/A
Y
SHARES TO BE SOLD TO COVER WITHHOLDING TAXES UPON VESTING OF RESTRICTED STOCK UNIT AWARDS
12/19/2024
/s/ Austin Rutherford, as Attorney-in-Fact